Skip to content

Duration of operation and cross-clamp time relative to cystatin C level of early-onset renal insufficiency in patients undergoing coronary artery bypass graft surgery,

Duration of operation and cross-clamp time relative to cystatin C level of early-onset renal insufficiency in patients undergoing coronary artery bypass graft surgery,

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000061134
Enrollment
10
Registered
2019-01-17
Start date
2018-11-06
Completion date
2019-03-10
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The development of renal failure is one of the major causes of morbidity and mortality after CABG surgery. Preoperative cystatin C levels in bypass surgery have been shown to be associated with postoperative renal failure development. One of the most important intraoperative risk factors for the development of renal failure is duration of operation and cross clamp time. Our aim is to determine the effect of the duration of operation and cross-clamp time on early-onset renal failure in patients undergoing CABG surgery by measuring cystatin C levels.

Interventions

1-2 µg / kg of fentanyl, 2-3 mg / kg of propofol and 0.6 mg / kg of rocuronium will be administered intravenously during induction of anesthesia. After 2 minutes the patient will be intubated. Central vein catheterization will be performed from right jugular vein. At this time, 5 ml of blood will be taken for cystatin C level and sent to the laboratory. Anticoagulation with 300 IU / kg heparin will be administered intravenously to enter the cardiopulmonary bypass. ACT (activated clotting time) v

1-2 µg / kg of fentanyl, 2-3 mg / kg of propofol and 0.6 mg / kg of rocuronium will be administered intravenously during induction of anesthesia. After 2 minutes the patient will be intubated. Central vein catheterization will be performed from right jugular vein. At this time, 5 ml of blood will be taken for cystatin C level and sent to the laboratory. Anticoagulation with 300 IU / kg heparin will be administered intravenously to enter the cardiopulmonary bypass. ACT (activated clotting time) values will be checked with ACT measurement device by periodic measurements for 30 minutes until cardiopulmonary bypass is stopped and cannulas are withdrawn. Hourly urine output, mediastinal drainage volume, duration of extubation will be noted. Blood samples for hemogram, BUN, creatine and cystatin C measurements will be taken at the 2nd and 24th hours postoperatively and sent to the laboratory. Blood samples taken for cystatin C will be stored at -80 ° C until assay time after centrifugation. Anesthesists will perform processes in the operating room and intensive care unit. Bioscience specialist will perform the processes in the laboratory Bypass operation will last for almost 3-4 hours and in intensive care unit hourly urine output, mediastinal drainage volume, duration of extubation, intraoperative and postoperative blood and blood product amounts given in the first 24 hours will be noted by anesthesists.

Sponsors

Mehmet Tercan
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Primary purpose
Diagnosis

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients undergoing coronary artery bypass graft surgery, Patients with normal renal function, elective surgery

Exclusion criteria

emergent surgery, pregnancy, patients undergoing heart valve surgery, diabetic nephropathy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026